New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
September 16, 2014
14:15 EDTSSHSunshine Heart rises after presenting data on C-Pulse system
Shares of medical device maker Sunshine Heart (SSH) have risen throughout the session after the company presented follow-up data from six patients implanted with its C-Pulse Heart Assist System as part of a FDA approved feasibility study. In slides made available on the company's website, Sunshine Heart stated that three of the six patients showed clinically significant improvement allowing for discontinuation of device support with explantation of the percutaneous lead. Additionally, Sunshine Heart's hosted its annual analyst and investor breakfast this morning at 7 am. In afternoon trading, shares of Sunshine Heart are up 9% to $6.36. Reference Link
07:36 EDTNCSCredit Suisse to hold a conference
Subscribe for More Information
07:27 EDTEWEdwards Lifesciences price target raised to $114 from $103 at Canaccord
Canaccord raised its price target on Edwards Lifesciences to $114 from $103 following positive updates on the SAPIEM franchise and on the heels of several positive trends and upside surprises across the businesses during the quarter. Canaccord maintains its Buy rating on the stock.
06:09 EDTSSHSunshine Heart to present data from six patients implanted with C-Pulse system
Sunshine Heart announced that follow-up data from six patients implanted with the C-Pulse Heart Assist System at St. Luke's Hospital Mid America Heart Institute, as part of a FDA approved, North American Feasibility Study, will be presented later today by Dr. Sanjeev Aggarwal, Director of Mechanical Circulatory Support at Saint Luke's Mid America Heart Institute. Prior to his clinical presentation at the TCT Conference, Dr. Aggarwal will present on a few of these patients who demonstrated clinical signs of myocardial recovery to the investment community at Sunshine Heart's fourth annual analyst and investor breakfast that begins at 7:00am today at the Grand Hyatt Washington.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use